How the vaccines produced in the EU will be distributed. Speak Scaccabarozzi (Farmindustria)
How will vaccines produced under subcontracting in individual countries be distributed to all European countries? Here are the answers from the president of Farmindustria, Massimo Scaccabarozzi
How will vaccines produced in subcontracting in individual countries be distributed to all European countries, for example in France given the announcements coming from Paris ?
This is the question that citizens are asking themselves after the news coming from France ( here the in-depth analysis of Start Magazine ).
"If the vaccines produced in the individual Member States are part of the agreements made between the pharmaceutical companies and the Commission, they will be distributed on the basis of the quotas established at European level for the different countries in a similar way to what is already happening – replies to Start Magazine. President of Farmindustria, Massimo Scaccabarozzi – Production is in fact global and the vaccines produced in the factories in Europe, thanks to the collaboration agreements both between pharmaceutical companies and contractors, will increase the total availability of anti-Covid 19 vaccines, allowing to accelerate vaccination campaigns ".
Italy too – like France and other European countries – is working towards the same objectives.
After the scouting among the companies operating in Italy done together with Farmindustria last week, the Minister of Economic Development Giancarlo Giorgetti announced in recent days that there are "at least four companies that are available for production in Italy directly or on behalf of third parties".
“In these days we are working on contracts with Invitalia which should finance these companies with a mix of concessions for the conversion of production lines and the purchase of new machinery”, Il Sole 24 Ore stressed today.
Meanwhile, at Mise the mouths on the names of these 4 companies in pole position are very stitched, but there are some possible candidates, wrote Marzio Bartoloni of Sole 24 Ore : "In particular the Haupt Pharma of Latina, the Rosia plant of the giant Gsk, the Catalent by Anagni, which already blows for AstraZeneca and Johnson & Johnson and finally the Apulian Lachifarma. But among the other possible candidates there are Thermo Fisher which has already closed an agreement with Pfizer to produce the vaccines of the American company in the Monza plants. And then there is also talk of Bion On, the Bolognese company with the accounts in red but with the dowry of five bioreactors necessary for the production of vaccines. Finally, a separate speech for the Reithera di Castel Romano company which is concluding the second phase of the experimentation of the all-Italian vaccine and which has already received funds and incentives from the Government as well as from Cnr and the Lazio Region ”.
Just to get this made in Italy vaccine supply chain off the ground, Mise put 400 million on the plate, added the Sun : "Two hundred million come from funds already in the budget of the Minister of Economic Development and become available with the ministerial decree signed by Minister Giorgetti on March 8 ".
This is a machine translation from Italian language of a post published on Start Magazine at the URL https://www.startmag.it/sanita/come-saranno-distribuiti-i-vaccini-prodotti-nellue-parla-scaccabarozzi-farmindustria/ on Tue, 06 Apr 2021 12:22:29 +0000.